Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group (Q33328841)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group |
scientific article |
Statements
1 reference
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group (English)
1 reference
J M Nabholtz
1 reference
H J Senn
1 reference
W R Bezwoda
1 reference
D Melnychuk
1 reference
L Deschênes
1 reference
J Douma
1 reference
T A Vandenberg
1 reference
B Rapoport
1 reference
R Rosso
1 reference
V Trillet-Lenoir
1 reference
J Drbal
1 reference
A Molino
1 reference
J W Nortier
1 reference
D J Richel
1 reference
T Nagykalnai
1 reference
P Siedlecki
1 reference
N Wilking
1 reference
J Y Genot
1 reference
P S Hupperets
1 reference
F Pannuti
1 reference
D Skarlos
1 reference
E M Tomiak
1 reference
M Murawsky
1 reference
M Alakl
1 reference
M Aapro
1 reference
1 reference
Identifiers
1 reference